Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Keywords: لنفوم فولیکولار; Follicular lymphoma; Bortezomib; Clinical trial; Phase II; Salvage therapy;